Cell line developer Selexis to be bought by JSR Life Sciences

By Gareth Macdonald contact

- Last updated on GMT

iStock/kasto80
iStock/kasto80

Related tags: Biotechnology

JSR Life Sciences has agreed to buy cell line developer Selexis SA.

The deal – financial terms of which were not disclosed – will see Selexis integrated into KBI Biopharma, a contract development and manufacturing organization JSR and partners CMIC Holdings Co., Innovation Network Corporation of Japan (INCJ) bought in 2015​.

Selexis’ core business is based on its SUREtechnology​ Platform, which is used to generate cell lines for the production of recombinant proteins.

According to JSR “KBI has performed development and or manufacturing services using more than 15 different Selexis generated cell lines since 2012​.”

News of the acquisition comes a few weeks after JSR announced its intention to spend $30m (€26m) to expand its biopharmaceutical manufacturing facilities in Durham, North Carolina and Boulder, Colorado.

In addition, KBI recently acquired​ a cell therapy manufacturing facility in Texas, and has previously announced plans to open an analytical services laboratory in Belgium.

Related topics: Bio Developments, Cell lines

Related news

Show more

Related products

show more

rAAV Production in BioBLU® Single-Use Vessels

rAAV Production in BioBLU® Single-Use Vessels

Eppendorf for Bioprocess – Solutions that grow with you | 25-Jun-2019 | Application Note

Rising interest in gene therapy-based applications leads to increasing demands in scalable production systems for viral vectors. Find out how Cevec Pharmaceuticals...

Small-Scale Cell Culture Perfusion Process

Small-Scale Cell Culture Perfusion Process

Eppendorf for Bioprocess – Solutions that grow with you | 29-Mar-2019 | Application Note

Perfusion cell culture processes promise advantages for industrial bioprocessing, like saving space, increasing volumetric productivity, achieving more...

Cultivation of 3D Cell Aggregates in Perfusion

Cultivation of 3D Cell Aggregates in Perfusion

Eppendorf for Bioprocess – Solutions that grow with you | 17-Sep-2018 | Application Note

3D cell aggregates are of great interest for applications like disease modeling and manufacturing of stem cell-based products. Read more about the cultivation...

Related suppliers

Follow us

Products

View more

Webinars